p73 induction after DNA damage is regulated by checkpoint kinases Chk1 and Chk2

Marshall Urist1, Tomoaki Tanaka, Masha V Poyurovsky

  • 1Department of Biological Sciences, Columbia University, New York, New York 10027, USA.

Genes & Development
|December 17, 2004
PubMed

Insights

Checkpoint kinases (Chk1 and Chk2) regulate the p73 protein in response to DNA damage. This pathway, independent of p53, offers potential for cancer drug development.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • Checkpoint kinases Chk1 and Chk2 are critical components of the DNA-damage response, mediating cell cycle arrest, DNA repair, and apoptosis.
  • The tumor suppressor protein p53 is frequently mutated in human cancers, limiting its therapeutic utility.
  • Understanding p53-independent pathways is crucial for developing novel anti-cancer strategies.

Purpose of the Study:

  • To investigate the role of Chk1 and Chk2 in regulating the p53-related transcription factor p73.
  • To elucidate the involvement of E2F1 in the Chk1/Chk2-p73 signaling axis.
  • To identify a p53-independent pathway for inducing apoptosis in cancer cells.

Main Methods:

  • Utilized multiple experimental systems in human tumor cell lines.
  • Interfered with or augmented Chk1/Chk2 signaling.
  • Analyzed p73 and E2F1 expression, accumulation, and activity following genotoxic stress.

Main Results:

  • Chk1 and Chk2 signaling directly controls p73 induction and mRNA accumulation in response to DNA damage.
  • E2F1 regulates p73 expression, and Chk1/Chk2 are essential for E2F1 stabilization and activity under genotoxic stress.
  • A functional pathway involving Chk1, Chk2, E2F1, and p73 mediates p53-independent apoptosis induced by cytotoxic drugs.

Conclusions:

  • The Chk1/Chk2-E2F1-p73 pathway represents a significant mechanism for p53-independent cell death.
  • This pathway is a promising target for developing novel anti-cancer therapeutics, particularly in p53-mutated tumors.
  • Targeting this pathway could overcome resistance to conventional cancer treatments.

Related Concept Videos

DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...